In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.

Abstract

Doripenem, a 1beta-methylcarbapenem, is a broad-spectrum antibiotic approved for the treatment of complicated urinary tract and complicated intra-abdominal infections. An indication for hospital-acquired pneumonia including ventilator-associated pneumonia is pending. The current study examined the activity of doripenem against recent clinical isolates for… (More)
DOI: 10.1128/AAC.00381-08

Topics

7 Figures and Tables

Cite this paper

@article{Pillar2008InVA, title={In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.}, author={Chris M. Pillar and Mohana K Torres and Nina P Brown and Dineshchandra O Shah and D. Sahm}, journal={Antimicrobial agents and chemotherapy}, year={2008}, volume={52 12}, pages={4388-99} }